Your browser doesn't support javascript.
loading
Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss.
Essers, Rick; Lebedev, Igor N; Kurg, Ants; Fonova, Elizaveta A; Stevens, Servi J C; Koeck, Rebekka M; von Rango, Ulrike; Brandts, Lloyd; Deligiannis, Spyridon Panagiotis; Nikitina, Tatyana V; Sazhenova, Elena A; Tolmacheva, Ekaterina N; Kashevarova, Anna A; Fedotov, Dmitry A; Demeneva, Viktoria V; Zhigalina, Daria I; Drozdov, Gleb V; Al-Nasiry, Salwan; Macville, Merryn V E; van den Wijngaard, Arthur; Dreesen, Jos; Paulussen, Aimee; Hoischen, Alexander; Brunner, Han G; Salumets, Andres; Zamani Esteki, Masoud.
Afiliação
  • Essers R; Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Lebedev IN; Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
  • Kurg A; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Fonova EA; Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
  • Stevens SJC; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Koeck RM; Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • von Rango U; Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
  • Brandts L; Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Deligiannis SP; Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
  • Nikitina TV; Department of Anatomy & Embryology, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
  • Sazhenova EA; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Tolmacheva EN; Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Kashevarova AA; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland.
  • Fedotov DA; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Demeneva VV; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Zhigalina DI; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Drozdov GV; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Al-Nasiry S; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Macville MVE; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • van den Wijngaard A; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Dreesen J; Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
  • Paulussen A; Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
  • Hoischen A; Department of Obstetrics and Gynaecology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Brunner HG; Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Salumets A; Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
  • Zamani Esteki M; Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Nat Med ; 29(12): 3233-3242, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37996709
ABSTRACT
Pregnancy loss is often caused by chromosomal abnormalities of the conceptus. The prevalence of these abnormalities and the allocation of (ab)normal cells in embryonic and placental lineages during intrauterine development remain elusive. In this study, we analyzed 1,745 spontaneous pregnancy losses and found that roughly half (50.4%) of the products of conception (POCs) were karyotypically abnormal, with maternal and paternal age independently contributing to the increased genomic aberration rate. We applied genome haplarithmisis to a subset of 94 pregnancy losses with normal parental and POC karyotypes. Genotyping of parental DNA as well as POC extra-embryonic mesoderm and chorionic villi DNA, representing embryonic and trophoblastic tissues, enabled characterization of the genomic landscape of both lineages. Of these pregnancy losses, 35.1% had chromosomal aberrations not previously detected by karyotyping, increasing the rate of aberrations of pregnancy losses to 67.8% by extrapolation. In contrast to viable pregnancies where mosaic chromosomal abnormalities are often restricted to chorionic villi, such as confined placental mosaicism, we found a higher degree of mosaic chromosomal imbalances in extra-embryonic mesoderm rather than chorionic villi. Our results stress the importance of scrutinizing the full allelic architecture of genomic abnormalities in pregnancy loss to improve clinical management and basic research of this devastating condition.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Placenta / Aborto Espontâneo Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Placenta / Aborto Espontâneo Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article